VANCOUVER, British Columbia--(BUSINESS WIRE)--Upstream Biosciences Inc. (OTCBB: UPBS) today announced that it has formed an independent committee of the board to evaluate and assess the strategic direction of the company. The committee consists of Mr. Jeffrey Bacha and Dr. Geert Cauwenbergh, who are the independent directors of the company.
